Description and Brand Names
Drug information provided by: Micromedex
US Brand Name
Lenalidomide is used to treat anemia (low red blood cells) in patients with a certain type of myelodysplastic syndrome (MDS). Patients with MDS may have very low red blood cell counts and require blood transfusions.
Lenalidomide is also used together with dexamethasone to treat multiple myeloma (plasma cell cancer) in patients who have received at least one previous treatment with another medicine.
Lenalidomide is also used to treat mantle cell lymphoma (MCL) in patients who have been treated previously with bortezomib plus one additional medicine that did not work well.
This medicine is available only with your doctor's prescription and through a special restricted distribution program called the Revlimid® REMS program.
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, lenalidomide is used in certain patients with the following medical condition:
Multiple myeloma, first-line treatment, in combination with dexamethasone (treatment of bone marrow cancer; used together with dexamethasone).
This product is available in the following dosage forms: